Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia
NCT05081349
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
91
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Hydroxycarbamide 500 Mg Oral Capsule+L-Carnitine
DRUG:
Hydroxycarbamide 500 Mg Oral Capsule
DRUG:
L-Carnitine, 250 Mg Oral Capsule
Sponsor
Assiut University